The global endoscopy devices market was valued at USD 37,218.5 million in 2017 and is anticipated to grow at a CAGR of 7.3% during the forecast period to reach USD 69,578.8 million by 2026. Endoscopy comprises an illuminated medical device that is used for visualization of the interiors of a hollow organ by inserting it into bodily cavities or small surgical incisions. It is a relatively safe and effective tool, mainly used in conjunction with other diagnostic modalities for diagnostic or therapeutic purposes.
由于其微创性质,手术后并发症更快,恢复时间更快,住院时间减少和最小的疤痕,因此对内窥镜检查装置的需求增加。此外,由于迅速增加的老年群体,糖尿病,肥胖和主要生活方式的变化,癌症,胃肠障碍和其他慢性疾病的患病率越来越大幅推动市场的增长。此外,患者意识和医生偏好的上升和若干技术进步进一步增加了市场增长。另一方面,合格内窥镜技术人员的普遍不足,初始投资的高成本和污染风险限制了市场增长。发展中经济体和技术进步的新兴市场为内窥镜检查设备增长提供了许多机会。
全球内窥镜设备市场在产品类型,应用程序,最终用户和区域的基础上进行分段。基于产品类型,该市场被分段为内窥镜,可视化系统,内窥镜检查和其他内窥镜检查设备。内窥镜区段进一步分段为刚性,柔性,胶囊和机器人辅助的内窥镜;可视化系统进一步分段为光源,相机头,内窥镜摄像头,发射机和接收器,无线显示和监视器,视频处理器和视频转换器等;内窥镜检查配件段进一步分叉进入组织采样装置,吸入陷阱,穿戴装置,外科分区,清洁刷,针夹和针钳等;而另一个内窥镜检查设备进一步分段为内窥镜检查流体管理系统,内窥镜检查超声等。在申请的基础上,该市场被分段为关节镜,支气管镜,心血管肺内窥镜,腹腔镜检查,耳鼻镜,胃肠内窥镜检查,泌尿外科内窥镜检查,妇科内窥镜检查,神经内科内窥镜检查和其他。最终用户段被分类为医院,诊所等。
This report comprises a detailed geographic distribution of the market across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America is further segmented into U.S. and Canada. Europe is divided into Germany, UK, and Rest of Europe. Asia-Pacific is bifurcated into China, Japan, India, and Rest of Asia-Pacific. The MEA region is further segmented into South Africa, Rest of Middle East & Africa. North America accounted for the largest share of the global endoscopy devices market in 2017. Influences for instance, favorable reimbursement scenario in the U.S., rising prevalence of cancer cases, growing investments and funds by hospitals and diagnostic centers to acquire advanced endoscopic equipment, growing research and development activities to improve endoscopy, and implementation of a new funding model for Canadian hospitals are contributing to the large share of North America.
全球内窥镜地区市场市场的关键参与者通过了合资和协议以及产品发布作为其主要市场战略。2017年10月,Olympus Corporation和Aries Pharmaceuticals,Inc。进入了一个联合促进协议,即FDA批准的即用型粘膜注射,为GI内窥镜切除提供了一种快速和持久的缓冲腺瘤,息肉和其他病变。2017年7月,Pentax Medical(Hoya Group司)和上海Aohua光电内窥镜有限公司(Aohua)进入了合资企业,以开发灵活医疗内窥镜检查领域的创新产品,以满足需求新兴市场。市场领先的球员包括奥林巴斯公司,波士顿科学公司,COOMIDIEN PLC,Covidien Plc,富士翁控股公司,Ethicon(Johnson&Johnson),Karl Storz GmbH,Stryker Corporation,Hoya Corporation(Pentax Medical System)和史密斯和侄子,其中包括其他。